| Literature DB >> 35199260 |
Kelly A Kyanko1, Molly A Fisher2, Latonya Riddle-Jones3, Anders Chen4, Francine Jetton5, Thomas Staiger4, Mark D Schwartz6.
Abstract
INTRODUCTION: Early or mid-career physicians have few opportunities to participate in career development programs in health policy and advocacy with experiential and mentored training that can be incorporated into their busy lives. AIM: The Society of General Internal Medicine (SGIM) created the Leadership in Health Policy (LEAHP) program, a year-long career development program, to prepare participants with a sufficient depth of knowledge, skills, attitudes, and behaviors to continue to build mastery and effectiveness as leaders, advocates, and educators in health policy. We sought to evaluate the program's impact on participants' self-efficacy in the core skills targeted in the curriculum. SETTING/PARTICIPANTS: Fifty-five junior faculty and trainees across three scholar cohorts from 2017 to 2021. PROGRAM DESCRIPTION: Activities included workshops and exercises at an annual meeting, one-on-one mentorship, monthly webinars and journal clubs, interaction with policy makers, and completion of capstone projects. PROGRAM EVALUATION: Self-administered, electronic surveys conducted before and following the year-long program showed a significant improvement in mean self-efficacy scores for the total score and for each of the six domains in general knowledge, teaching, research, and advocacy in health policy. Compared to the baseline scores, after the program the total mean score increased from 3.1 to 4.1, an increase of 1.1 points on a 5-point Likert scale (95% CI: 0.9-1.3; Cohen's D: 1.7), with 61.4% of respondents increasing their mean score by at least 1 point. Responses to open-ended questions indicated that the program met scholars' stated needs to improve their knowledge base in health policy and advocacy skills. DISCUSSION: The LEAHP program provides an opportunity for mentored, experiential training in health policy and advocacy, can build the knowledge and amplify the scale of physicians engaged in health policy, and help move physicians from individual patient advocacy in the clinic to that of populations.Entities:
Keywords: health policy; training program
Year: 2022 PMID: 35199260 PMCID: PMC8865497 DOI: 10.1007/s11606-022-07455-y
Source DB: PubMed Journal: J Gen Intern Med ISSN: 0884-8734 Impact factor: 5.128
Major Domains and Learning Objectives of the Leadership in Health Policy Program
| Scale domain and learning objectives (Cronbach’s alpha coefficient for domain scales, | |
|---|---|
| General (0.90) | |
| • Describe the key structures and functions of the American healthcare system | |
| • Describe the federal health policy apparatus—key institutions and leaders | |
| • Explain the key decision-makers and timeline of the federal budgeting process | |
| • Explain the distinctions between authorization and appropriation legislation | |
| • Define the distinctions between mandatory and discretionary spending | |
| • Compare various healthcare cost control strategies | |
| • Describe at least 10 of the Affordable Care Act’s (ACA) key provisions | |
| • Note 3 current problems in the ACA that would require legislative action | |
| • Explain the rulemaking process—how policy is implemented and regulated | |
| • Describe the variability in how health policy is implemented across the states | |
| • Name at least 5 key moments in the history of American health policy | |
| Clinical practice (0.73) | |
| • Explain how healthcare systems shape variation in outcomes | |
| • Describe the basics of how healthcare is financed by public and private payers | |
| • Describe how the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) is reshaping physician payment policy | |
| • Explain the rules driving the Alternate Payment Model and Merit–based Incentive Payment System provisions in MACRA | |
| • Compare various “value-based” clinician payment policies and how each differs from prior payment policies | |
| • Describe how the Centers for Medicare and Medicaid Services (CMS) develops and implements the physician fee schedule | |
| • Explain the deficiencies and consequences of the regulations regarding Evaluation and Management coding | |
| • Describe strategies for promoting quality measures and incentives | |
| Education (0.78) | |
| • Explain how Medicare policy shapes graduate medical education (GME) financing and programs | |
| • Describe the ongoing debate on how to reform GME financing | |
| • Explain how federal policy impacts the health professional workforce | |
| • Describe the historical context of Title 7 programs and how it has evolved | |
| • Describe how public GME funding contributes to the financial viability of academic medical centers | |
| Research (0.82) | |
| • Describe how the appropriations process shapes research priorities | |
| • Explain how the missions and priorities of PCORI and AHRQ compare | |
| • Describe the major executive branch agencies with authority over research | |
| • Provide examples of how federal regulations impact research priorities | |
| Advocacy (0.92) | |
| • Compare strategies and challenges of advocacy at the state level compared with the federal level | |
| • How to prepare leave-behind materials for advocacy visits | |
| • How to optimize talking points for advocacy visits | |
| • Effective communication strategies with policy makers | |
| • Describe the mission and health policy priorities of other professional societies | |
| • Explain how to build and leverage coalitions in health policy advocacy | |
| • Describe how administrative advocacy differs from legislative advocacy | |
| Teaching health policy (0.91) | |
| • Design a curriculum on health policy for medical students or residents | |
| • Prepare a lecture on the strengths and limitations of the ACA | |
| • Integrate health policy education into teaching that I already do | |
| • Lead a journal club on an article about a health policy topic |
Figure 1Program design of the Leadership in Health Policy (LEAHP) Program
Characteristics of the LEAHP Program Scholars
| Cohort year | Number of scholars | % Female | % URiM* | % Trainees | % Faculty |
|---|---|---|---|---|---|
| 2017–2018 | 19 | 73.7 | 10.5 | 10.5 | 89.5 |
| 2018–2019 | 14 | 71.4 | 14.3 | 21.4 | 78.6 |
| 2020–2021 | 22 | 54.5 | 18.2 | 13.6 | 86.4 |
| Totals | 55 | 65.5 | 14.5 | 14.5 | 85.5 |
*Underrepresented in medicine, defined as Black/African American, Hispanic/Latino, American Indians or Alaska Natives, or Native Hawaiians and other Pacific Islanders
Mean Self-efficacy Scores for Each Health Policy Domain Scale Before and After the Program (N=44)
| Domain scale | Pre-program mean (SD) | Post-program mean (SD) | Pre-post program mean difference (95% CI)* | % with pre-post mean change | Cohen’s |
|---|---|---|---|---|---|
| General | 2.9 (0.7) | 4.1 (0.5) | 1.1 (0.9, 1.4) | 65.9 | 1.5 |
| Practice | 3.3 (0.7) | 4.2 (0.5) | 1.0 (0.7, 1.2) | 50.0 | 1.2 |
| Education | 3.0 (0.7) | 4.1 (0.6) | 1.2 (0.9, 1.4) | 58.1 | 1.3 |
| Research | 2.3 (0.7) | 3.8 (0.7) | 1.4 (1.2, 1.7) | 70.5 | 1.6 |
| Advocacy | 3.4 (0.7) | 4.4 (0.5) | 1.0 (0.7, 1.2) | 47.7 | 1.4 |
| Teaching | 3.5 (0.9) | 4.4 (0.6) | 0.9 (0.7, 1.1) | 50.0 | 1.0 |
| Total score | 3.1 (0.5) | 4.1 (0.4) | 1.1 (0.9, 1.3) | 61.4 | 1.7 |
Participants rated on a 5-point Likert scale the degree to which they agreed with self-efficacy statements based on the program’s learning objectives. For example, “I can describe the key structures and functions of the American healthcare system.” (1 = Strongly disagree; 2 = Disagree; 3 = Neutral; 4 = Agree; and 5 = Strongly disagree)
Forty-four participants that completed both the pre-program and the post-program surveys
*p<0.001 for all comparisons
†Effect size for difference between pre-program and post-program means, all large effects
Themes Identified in Open-Ended Questions with Representative Quotations
| Themes | Comments exhibiting theme ( | Representative quote |
|---|---|---|
| Q1: What are the three things you want to be able to do as a result of this program that you are unable to do now? ( | ||
| Advocacy skills | 63 (40%) | “Improve ability to articulate gaps in our health care system and the improve my ability to communicate concerns effectively at various levels” |
| Improve knowledge base of health policy | 45 (29%) | “Have a deeper understanding of how health policy is crafted and implemented” |
| Teaching | 32 (20%) | “Be better and more effective in development and implementation of a health policy curriculum for undergraduate and postgraduate medical education” |
| Publications and writing | 13 (8%) | “Draft policy papers and op-eds explaining and advocating for various positions” |
| Q2: Name three things you have learned this year that you think will have enduring value for you. ( | ||
| Physician as advocate | 48 (37%) | “I have learned, quite tangibly, the power of using my voice (and pen) to advocate for (or against) policy issues that have a significant impact on the lives of my patients and community.” |
| Health policy process | 31 (24%) | “Much clearer understanding of the process by which a bill is created and becomes a law. I also now understand where in that process advocacy is possible and helpful.” |
| Payment and reimbursement | 29 (22%) | “Complexity of our health financing and payment system and how competing interests impact progress” |
| Networking among colleagues | 15 (12%) | “Working with my LEAHP cohorts: this was very enjoyable to see others’ speaking skills, interests, etc. Although I have been interested in health policy for some time, it became more of a “team sport” through interactions with colleagues. I have learned the value of conference calls, etc. - as silly as that may sound, it is encouraging to see how cross-institutional work can be realistically completed.” |
| Q3: What were the most meaningful or helpful elements of the program for you? ( | ||
| Mentorship | 22 (28%) | “The direct mentoring was incredibly valuable in pushing me to think bigger about what I could achieve” |
| Collaboration with colleagues | 22 (28%) | “The opportunity to work across institutions on a policy curriculum has been career-changing for me. Whereas many academic groups tend to become territorial about collaboration, the LEAHP cohort was united by a common (and very passionate) desire to develop future leaders in General Internal Medicine through a standardized curriculum. In addition to the excitement of taking on this big dream so many of us already seemed to share, I made lifelong friends and colleagues across the country, with whom I will now (hopefully!) take on future tasks.” |
| Didactics and instructional strategies | 19 (24%) | “The webinars and monthly workshops were very helpful in hearing other’s ideas, critically thinking about policy and broadening knowledge.” |
| Advocacy in action | 12 (15%) | “Hill Day was very meaningful. I felt this year much more prepared than the first time I went.” |
| Q4: What suggestions do you have for building or strengthening the impact of the program for future cohorts? ( | ||
| Increase connectivity and meet-ups | 11 (37%) | “More frequent but less formal times to gather - casual happy hours for a topic or discussion.” |
| Collaborative projects | 5 (17%) | “I know group work is always challenging, but maybe more small group work. I was involved with three SGIM workshops (which we set up independently with current LEAHPers and mentors) and the meetings and discussions for those projects were very helpful. I also think this helped form some lasting bonds for future work since we all met multiple times to set these projects up.” |
| More basic didactics | 4 (13%) | “Would love to have discussion on the basics - review of glossary terms and what they mean and truly entail.” |
| Peer mentors | 4 (13%) | “I think peer mentors would be helpful - making a connection early with someone who had gone through the program already would be helpful in brainstorming projects and just collaboration on a broader scale.” |
*Percentages do not round to 100% as a small number of comments did not align with any of the predominant themes and were not coded. Q1: 4/157 (3%); Q2: 7/130 (5%); Q3: 3/78 (4%); Q4: 6/30 (20%); Total 20/395 (5%)
†Question 4 was completed only by the last two cohorts